US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Moderna, Inc. - Common Stock (NQ:MRNA)

190.01 +1.07 (+0.57%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
What's going on in today's session: S&P500 most active stocks ↗
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Monday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
1 Large-Cap Stock with Impressive Fundamentals and 2 We Turn Down
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are... 
Via StockStory
News headline image
Why Tempus AI Skyrocketed This Week ↗
Tempus AI's latest acquisition is looking like a great move. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
Which S&P500 stocks have an unusual volume on Friday? ↗
Via Chartmill
News headline image
2 Biotech Stocks Shaping Up for Major Breakouts ↗
Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera both show strong uptrends and possible breakouts. 
Via MarketBeat
Topics ETFs
News headline image
Breakfast News: A Conversation With Ionis CEO ↗
Ionis Pharmaceuticals CEO on a major profitability milestone, breakthrough medicines and more. 
Via The Motley Fool
Topics ETFs World Trade
News headline image
MarketBeat Week in Review – 08/17 - 08/21 ↗
Stocks fell this week as Treasury bond buybacks, oil prices, and Walmart earnings weighed on markets, while Bitcoin rallied; MarketBeat analysts cover Moderna, NVIDIA, Meta, RTX, and more. 
Via MarketBeat
Topics Bonds ETFs Economy
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Which S&P500 stocks are the most active on Friday? ↗
Via Chartmill
Friday's session: most active stocks ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Moderna’s 177% Surge Has Investors Asking What Comes Next ↗
Moderna shares surged 177% after its melanoma vaccine, developed with Merck, outperformed an established therapy in a late-stage trial, triggering a massive short squeeze. 
Via MarketBeat
Walmart's Guide-Down Sinks the Dow as Trump Readies an "Economic D-Day" for Iran ↗
Via Chartmill
Topics Government Stocks
News headline image
Moderna's Comeback Is Finally Taking Shape -- and There May Be More Upside Ahead ↗
Breaking news: Moderna isn't just a "pandemic stock" after all. 
Via The Motley Fool
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Looking for the most active stocks in the S&P500 index on Thursday? ↗
Via Chartmill
Thursday's session: most active stocks ↗
Via Chartmill
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗
Via Chartmill
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Why Moderna (MRNA) Stock Is Trading Lower Today
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 20% in the morning session after investors took profits as the stock surged over 17... 
Via StockStory
Topics Artificial Intelligence
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
Moderna Doubles on Melanoma Vaccine Win, Treasury Steps In to Cap Long-End Yields ↗
Via Chartmill
News headline image
Why Moderna Stock Skyrocketed Today ↗
The biotech could be on the verge of setting a new standard of care for skin cancer. 
Via The Motley Fool
News headline image
Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma Data ↗
Today, Aug. 19, 2026, Moderna's personalized cancer vaccine met its late-stage goal, with the company and Merck planning an FDA submission. 
Via The Motley Fool
Topics Stocks
What's going on in today's after hours session ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Here are the top movers in Wednesday's session. ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >